S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
OTCMKTS:EKTAY

Elekta AB (publ) (EKTAY) Stock Price, News & Analysis

$7.09
+0.07 (+1.00%)
(As of 04/15/2024 ET)
Today's Range
$7.03
$7.15
50-Day Range
$6.99
$7.82
52-Week Range
$6.52
$8.65
Volume
5,581 shs
Average Volume
6,511 shs
Market Capitalization
$2.72 billion
P/E Ratio
19.69
Dividend Yield
2.26%
Price Target
N/A

Elekta AB (publ) MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.00% of Shares Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
0.65mentions of Elekta AB (publ) in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
14.63%
From $0.41 to $0.47 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.01 out of 5 stars

EKTAY stock logo

About Elekta AB (publ) Stock (OTCMKTS:EKTAY)

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services. It also provides Elekta Studio, an image guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; Geneva, an applicator for cervical cancer treatment; veterinary radiation therapy products; and Elekta Kaiku for personalized cancer care. In addition, the company offers stereotactic radiosurgery, such as Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for radiosurgeons; and Elekta Esprit. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System for minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.

EKTAY Stock Price History

EKTAY Stock News Headlines

Elekta AB (publ) goes ex dividend Monday
Bitcoin Rockets To Record High But Buy THIS Instead
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
Is Elekta (EKTAY) Stock Undervalued Right Now?
Is Elekta (EKTAY) a Great Value Stock Right Now?
Elekta AB ADR EKTAY
Bitcoin Rockets To Record High But Buy THIS Instead
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
Elekta AB Series B
Elekta AB (publ) (EKTAY)
Elekta AB (publ) (EKTA-B.ST)
ELEKTA B SHS ADR (OTC: EKTAY)
Elekta AB (publ)
Elekta (EKTAY) Presents at ESTRO 2022
Elekta: Interim report, May-January 2021/22
New finance chief at Elekta
See More Headlines
Receive EKTAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Elekta AB (publ) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 3/18 Dividend
2/26/2024
Last Earnings
2/29/2024
Dividend Payable
3/18/2024
Today
4/16/2024
Fiscal Year End
4/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical laboratories
Sub-Industry
N/A
Current Symbol
OTCMKTS:EKTAY
Employees
4,540
Year Founded
N/A

Profitability

Net Income
$90.25 million
Pretax Margin
8.25%

Debt

Sales & Book Value

Annual Sales
$1.61 billion
Cash Flow
$0.57 per share
Book Value
$2.43 per share

Miscellaneous

Free Float
225,231,000
Market Cap
$2.72 billion
Optionable
Not Optionable
Beta
1.16
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Dr. Laurent Leksell (Age 72)
    Founder & Chairman
    Comp: $1.64M
  • Mr. Gustaf Salford (Age 47)
    President & CEO
    Comp: $14.62M
  • Mr. Tobias Hagglov (Age 46)
    Chief Financial Officer
  • Mr. Peter Nyquist (Age 59)
    Head of Investor Relations
  • Mr. Jonas Bolander (Age 58)
    Executive VP of Group Functions, Secretary & General Counsel
  • Mr. Mattias Thorsson
    VP and Head of Corporate Communications & Public Affairs
  • Ms. Anna Conneryd Lundgren (Age 39)
    Executive VP & Chief People Officer
  • Mr. John Lapré (Age 60)
    President of Brachy & Neuro Solutions
  • Mr. Maurits Wolleswinkel (Age 53)
    President of Linac & Software Solutions
  • Mr. Habib Nehme (Age 60)
    Chief Commercial Officer

EKTAY Stock Analysis - Frequently Asked Questions

Should I buy or sell Elekta AB (publ) stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Elekta AB (publ) in the last year. There are currently 2 sell ratings for the stock. The consensus among Wall Street research analysts is that investors should "sell" EKTAY shares.
View EKTAY analyst ratings
or view top-rated stocks.

How have EKTAY shares performed in 2024?

Elekta AB (publ)'s stock was trading at $8.1495 at the start of the year. Since then, EKTAY stock has decreased by 13.0% and is now trading at $7.09.
View the best growth stocks for 2024 here
.

Are investors shorting Elekta AB (publ)?

Elekta AB (publ) saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 2,400 shares, an increase of 71.4% from the March 15th total of 1,400 shares. Based on an average daily volume of 9,000 shares, the days-to-cover ratio is presently 0.3 days.
View Elekta AB (publ)'s Short Interest
.

How were Elekta AB (publ)'s earnings last quarter?

Elekta AB (publ) (OTCMKTS:EKTAY) released its quarterly earnings results on Thursday, February, 29th. The company reported $0.08 EPS for the quarter. The business earned $426.51 million during the quarter. Elekta AB (publ) had a trailing twelve-month return on equity of 15.16% and a net margin of 7.88%.

How often does Elekta AB (publ) pay dividends? What is the dividend yield for Elekta AB (publ)?

Elekta AB (publ) declared a dividend on Tuesday, January 30th. Stockholders of record on Tuesday, February 27th will be paid a dividend of $0.1146 per share on Monday, March 18th. The ex-dividend date is Monday, February 26th.
Read our dividend analysis for EKTAY
.

Is Elekta AB (publ) a good dividend stock?

Elekta AB (publ) (OTCMKTS:EKTAY) pays an annual dividend of $0.16 per share and currently has a dividend yield of 2.26%. The dividend payout ratio is 44.44%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, EKTAY will have a dividend payout ratio of 34.04% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for EKTAY.

How do I buy shares of Elekta AB (publ)?

Shares of EKTAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:EKTAY) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners